SRRA logo

Sierra Oncology (SRRA) Financials

Balance sheets

31 Mar 202231 Dec 202130 Sept 202130 June 202131 Mar 202131 Dec 202030 Sept 202030 June 202031 Mar 2020

Total Assets

$280.0 M(+156.0%)$109.4 M(+4.9%)$104.2 M(+10.4%)$94.4 M(-14.6%)$110.6 M(+2.9%)$107.5 M(-4.9%)$113.0 M(-10.2%)$125.9 M(-8.0%)$136.8 M

Current Assets

$278.2 M(+159.1%)$107.4 M(+4.5%)$102.7 M(+10.8%)$92.7 M(-15.5%)$109.7 M(+3.0%)$106.5 M(-4.9%)$112.0 M(-10.2%)$124.6 M(-8.0%)$135.5 M

Non Current Assets

$1.8 M(-8.7%)$2.0 M(+30.6%)$1.5 M(-11.3%)$1.7 M(+90.4%)$895.0 K(-12.0%)$1.0 M(-5.3%)$1.1 M(-15.3%)$1.3 M(-4.0%)$1.3 M

Total Liabilities

$18.4 M(+37.5%)$13.4 M(+45.8%)$9.2 M(-9.3%)$10.1 M(+12.2%)$9.0 M(-5.5%)$9.5 M(+24.0%)$7.7 M(-16.9%)$9.2 M(+26.7%)$7.3 M

Current Liabilities

$13.1 M(+1.5%)$12.9 M(+49.4%)$8.6 M(-8.8%)$9.5 M(+6.5%)$8.9 M(-5.0%)$9.4 M(+25.3%)$7.5 M(-16.9%)$9.0 M(+28.4%)$7.0 M

Long Term Liabilities

$5.3 M(+992.4%)$485.0 K(-10.7%)$543.0 K(-16.5%)$650.0 K(+432.8%)$122.0 K(-30.3%)$175.0 K(-19.4%)$217.0 K(-16.9%)$261.0 K(-12.4%)$298.0 K

Shareholders Equity

$261.6 M(+172.5%)$96.0 M(+1.0%)$95.1 M(+12.8%)$84.3 M(-17.0%)$101.6 M(+3.7%)$98.0 M(-7.0%)$105.4 M(-9.7%)$116.7 M(-9.9%)$129.5 M

Book Value

$261.6 M(+172.5%)$96.0 M(+1.0%)$95.1 M(+12.8%)$84.3 M(-17.0%)$101.6 M(+3.7%)$98.0 M(-7.0%)$105.4 M(-9.7%)$116.7 M(-9.9%)$129.5 M

Working Capital

$265.1 M(+180.5%)$94.5 M(+0.5%)$94.1 M(+13.1%)$83.2 M(-17.4%)$100.8 M(+3.8%)$97.1 M(-7.1%)$104.5 M(-9.6%)$115.6 M(-10.0%)$128.5 M

Cash And Cash Equivalents

$274.0 M(+161.6%)$104.7 M(+7.9%)$97.1 M(+7.0%)$90.7 M(-15.8%)$107.7 M(+3.5%)$104.1 M(-4.5%)$109.0 M(-11.5%)$123.2 M(-7.7%)$133.5 M

Accounts Payable

$1.8 M(-16.7%)$2.2 M(+155.1%)$846.0 K(-45.4%)$1.5 M(-38.6%)$2.5 M(+14.4%)$2.2 M(+43.2%)$1.5 M(-22.3%)$2.0 M(+46.1%)$1.4 M

Accounts Receivable

---------

Short Term Debt

$318.0 K(-13.6%)$368.0 K(-9.8%)$408.0 K(+14.6%)$356.0 K(+66.4%)$214.0 K(+3.4%)$207.0 K(+7.3%)$193.0 K(+4.3%)$185.0 K(+5.7%)$175.0 K

Long Term Debt

$5.3 M(+992.4%)$485.0 K(-10.7%)$543.0 K(-16.5%)$650.0 K(+432.8%)$122.0 K(-30.3%)$175.0 K(-19.4%)$217.0 K(-16.9%)$261.0 K(-12.4%)$298.0 K

Total Debt

$5.6 M(+558.4%)$853.0 K(-10.3%)$951.0 K(-5.5%)$1.0 M(+199.4%)$336.0 K(-12.0%)$382.0 K(-6.8%)$410.0 K(-8.1%)$446.0 K(-5.7%)$473.0 K

Debt To Equity

0.0(+100.0%)0.0(0%)0.0(0%)0.0(+100.0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0

Current Ratio

21.3(+155.0%)8.3(-30.0%)11.9(+21.5%)9.8(-20.6%)12.3(+8.4%)11.4(-24.1%)15.0(+8.1%)13.9(-28.3%)19.4

Quick Ratio

---------

Inventory

---------

Retained Earnings

-$969.2 M(-3.0%)-$941.2 M(-2.8%)-$915.8 M(-3.2%)-$887.1 M(-2.4%)-$866.5 M(-2.4%)-$846.6 M(-2.2%)-$828.6 M(-1.8%)-$814.1 M(-2.1%)-$797.6 M

PB Ratio

2.9(-17.3%)3.5(+5.7%)3.3(+16.8%)2.9(+36.2%)2.1(+15.4%)1.8(+71.7%)1.1(-1.9%)1.1(+36.7%)0.8

Income statements

31 Mar 202231 Dec 202130 Sept 202130 June 202131 Mar 202131 Dec 202030 Sept 202030 June 202031 Mar 2020

EPS

-$1.3(+20.4%)-$1.7(+20.5%)-$2.1(-25.8%)-$1.7(+2.3%)-$1.7(-4.9%)-$1.6(-17.3%)-$1.4(+12.0%)-$1.6(+49.7%)-$3.1

TTM EPS

-$6.8(+5.3%)-$7.2(-0.6%)-$7.1(-11.1%)-$6.4(-1.4%)-$6.3(+18.5%)-$7.7(+44.7%)-$14.0(+28.3%)-$19.5(+24.7%)-$25.9

Revenue

-----$200.0 K(+100.0%)$100.0 K--

TTM Revenue

-----$300.0 K(+200.0%)$100.0 K--

Total Expenses

$27.9 M(+9.0%)$25.6 M(-10.5%)$28.6 M(+39.0%)$20.6 M(+3.8%)$19.8 M(+9.4%)$18.1 M(+24.5%)$14.5 M(-11.6%)$16.4 M(+1.9%)$16.1 M

Operating Expenses

$27.9 M(+9.0%)$25.6 M(-10.5%)$28.6 M(+39.0%)$20.6 M(+3.8%)$19.8 M(+9.4%)$18.1 M(+24.5%)$14.5 M(-11.6%)$16.4 M(+1.9%)$16.1 M

Cost Of Goods Sold

---------

TTM Cost Of Goods Sold

---------

Gross Profit

---------

TTM Gross Profit

---------

Gross Margin

---------

Operating Profit

-$27.9 M(-9.0%)-$25.6 M(+10.5%)-$28.6 M(-39.0%)-$20.6 M(-3.8%)-$19.8 M(-10.6%)-$17.9 M(-24.0%)-$14.4 M(+12.2%)-$16.4 M(-1.9%)-$16.1 M

TTM Operating Profit

-$102.7 M(-8.5%)-$94.6 M(-8.8%)-$86.9 M(-19.5%)-$72.7 M(-6.0%)-$68.6 M(-5.7%)-$64.9 M(+9.9%)-$72.0 M(-1.7%)-$70.9 M(-1.8%)-$69.6 M

Operating Margin

------8956.5%(+38.0%)-14.4 K%--

Net Income

-$27.9 M(-9.7%)-$25.5 M(+11.1%)-$28.6 M(-38.9%)-$20.6 M(-3.6%)-$19.9 M(-10.5%)-$18.0 M(-24.3%)-$14.5 M(+11.9%)-$16.5 M(+48.4%)-$31.9 M

TTM Net Income

-$102.7 M(-8.5%)-$94.7 M(-8.5%)-$87.2 M(-19.4%)-$73.1 M(-6.0%)-$68.9 M(+14.8%)-$80.9 M(+26.7%)-$110.3 M(-1.5%)-$108.7 M(-1.5%)-$107.2 M

Net Margin

------9011.5%(+37.9%)-14.5 K%--

EBIT

-$27.9 M(-9.0%)-$25.6 M(+10.5%)-$28.6 M(-39.0%)-$20.6 M(-3.8%)-$19.8 M(-10.6%)-$17.9 M(-24.0%)-$14.4 M(+12.2%)-$16.4 M(-1.9%)-$16.1 M

TTM EBIT

-$102.7 M(-8.5%)-$94.6 M(-8.8%)-$86.9 M(-19.5%)-$72.7 M(-6.0%)-$68.6 M(-5.7%)-$64.9 M(+9.9%)-$72.0 M(-1.7%)-$70.9 M(-1.8%)-$69.6 M

EBITDA

-$27.8 M(-9.0%)-$25.5 M(+10.6%)-$28.5 M(-39.1%)-$20.5 M(-3.7%)-$19.8 M(-10.7%)-$17.9 M(-24.4%)-$14.4 M(+12.3%)-$16.4 M(-1.9%)-$16.1 M

TTM EBITDA

-$102.3 M(-8.5%)-$94.3 M(-8.8%)-$86.6 M(-19.5%)-$72.5 M(-6.0%)-$68.4 M(-5.7%)-$64.7 M(+9.9%)-$71.9 M(-1.6%)-$70.7 M(-1.8%)-$69.4 M

Selling, General & Administrative Expenses

$10.3 M(+26.6%)$8.2 M(+16.8%)$7.0 M(+8.7%)$6.4 M(+9.5%)$5.9 M(+12.6%)$5.2 M(+26.6%)$4.1 M(-34.3%)$6.3 M(+37.8%)$4.5 M

TTM SG&A

$31.9 M(+16.3%)$27.4 M(+12.1%)$24.5 M(+13.3%)$21.6 M(+0.8%)$21.4 M(+6.6%)$20.1 M(+7.8%)$18.7 M(+5.4%)$17.7 M(+18.6%)$14.9 M

Depreciation And Amortization

$92.0 K(0%)$92.0 K(+2.2%)$90.0 K(+18.4%)$76.0 K(+61.7%)$47.0 K(0%)$47.0 K(-39.7%)$78.0 K(+34.5%)$58.0 K(+5.5%)$55.0 K

TTM D&A

$350.0 K(+14.8%)$305.0 K(+17.3%)$260.0 K(+4.8%)$248.0 K(+7.8%)$230.0 K(-3.4%)$238.0 K(+176.7%)$86.0 K(+22.9%)$70.0 K(-7.9%)$76.0 K

Interest Expense

---------

TTM Interest Expense

---------

Income Tax

-$14.0 K(+89.0%)-$127.0 K(-370.2%)$47.0 K(+422.2%)$9000.0(-86.8%)$68.0 K(+88.9%)$36.0 K(-7.7%)$39.0 K(+454.6%)-$11.0 K(-114.1%)$78.0 K

TTM Income Tax

-$85.0 K(-2733.3%)-$3000.0(-101.9%)$160.0 K(+5.3%)$152.0 K(+15.2%)$132.0 K(-7.0%)$142.0 K(-2.1%)$145.0 K(+339.4%)$33.0 K(-47.6%)$63.0 K

PE Ratio

---------

PS Ratio

-----594.6(-46.9%)1119.9--

Cashflow statements

31 Mar 202231 Dec 202130 Sept 202130 June 202131 Mar 202131 Dec 202030 Sept 202030 June 202031 Mar 2020

Cash From Operations

-$25.7 M(-68.8%)-$15.3 M(+48.7%)-$29.7 M(-74.9%)-$17.0 M(-0.3%)-$17.0 M(-33.0%)-$12.7 M(+17.2%)-$15.4 M(-49.8%)-$10.3 M(+26.3%)-$13.9 M

TTM CFO

-$87.7 M(-11.1%)-$79.0 M(-3.3%)-$76.5 M(-23.1%)-$62.1 M(-12.2%)-$55.4 M(-5.8%)-$52.4 M(-0.6%)-$52.1 M(-9.0%)-$47.8 M(+3.6%)-$49.6 M

Cash From Investing

-$62.0 K(-93.8%)-$32.0 K(-100.0%)$0.0(+100.0%)-$40.0 K(-100.0%)$0.0(0%)$0.0(0%)$0.0(+100.0%)-$12.0 K(-100.0%)$0.0

TTM CFI

-$134.0 K(-86.1%)-$72.0 K(-80.0%)-$40.0 K(0%)-$40.0 K(-233.3%)-$12.0 K(0%)-$12.0 K(+33.3%)-$18.0 K(+43.8%)-$32.0 K(-28.0%)-$25.0 K

Cash From Financing

$195.1 M(+749.7%)$23.0 M(-36.5%)$36.2 M(+31898.2%)$113.0 K(-99.5%)$20.6 M(+165.2%)$7.8 M(+580.8%)$1.1 M(+100.0%)$0.0(0%)$0.0

TTM CFF

$254.3 M(+218.6%)$79.8 M(+23.5%)$64.6 M(+118.3%)$29.6 M(+0.4%)$29.5 M(+231.2%)$8.9 M(-90.5%)$93.4 M(+1.2%)$92.3 M(0%)$92.3 M

Free Cash Flow

-$25.8 M(-68.8%)-$15.3 M(+48.6%)-$29.7 M(-74.5%)-$17.0 M(-0.5%)-$17.0 M(-33.0%)-$12.7 M(+17.2%)-$15.4 M(-49.6%)-$10.3 M(+26.2%)-$13.9 M

TTM FCF

-$87.9 M(-11.2%)-$79.0 M(-3.3%)-$76.5 M(-23.1%)-$62.1 M(-12.2%)-$55.4 M(-5.8%)-$52.4 M(-0.6%)-$52.1 M(-8.9%)-$47.8 M(+3.6%)-$49.6 M

CAPEX

-----$0.0(0%)$0.0--

TTM CAPEX

-----$0.0(0%)$0.0--

Dividends Paid

---------

TTM Dividends Paid

---------

TTM Dividend Per Share

---------

TTM Dividend Yield

---------

Payout Ratio

---------